• PTPN2 Restrains Psoriasis via STING–STAT3 and Autophagy

  2026-09-26

  A 2026 study identifies PTPN2 as a negative regulator of the STING–STAT3 pathway in psoriasis models, linking its phosphatase activity to reduced keratinocyte proliferation, increased apoptosis and autophagy, and lower inflammatory cytokine output. The combined cellular and mouse evidence positions PTPN2 as a candidate regulator of skin inflammation while highlighting experimental questions about pathway specificity and translation to human disease.

• Anti-HMGB1 Rabbit Monoclonal Antibody Guide

  2026-09-25

  The Anti-HMGB1 Rabbit Monoclonal Antibody (MA3057) supports research detection of HMGB1 in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. Use it to investigate HMGB1 protein in controlled laboratory workflows; it is not validated for diagnostic, medical, or therapeutic use.

• Dhcr7 Knockout Grass Carp Show GCRV Resistance

  2026-09-25

  A 2026 grass carp study used CRISPR/Cas9 disruption of dhcr7 to test whether a cholesterol-biosynthesis enzyme influences resistance to GCRV-II. Edited fish showed higher survival, stronger Irf3-associated antiviral responses, lower viral burden, and less hepatopancreas damage, without detected changes in the measured growth and muscle outcomes.

• Tobramycin Workflows for Bacterial Research

  2026-09-24

  Build reproducible broth-based assays with Tobramycin, from aqueous stock preparation to MIC measurement and resistance-focused comparisons. A classic sisomicin study offers useful experimental design lessons—but its isolate results should not be mistaken for contemporary Tobramycin susceptibility data.

• PLGA Microspheres for Corticosteroid Delivery in Cartilage

  2026-09-24

  A 2026 study evaluates how PLGA microsphere size and surface chemistry affect corticosteroid transport and stability in cartilage. Its key contribution is showing that particle movement cannot be understood from simple diffusion fits alone, while PEGylation can preserve more hydrocortisone 17-butyrate during release.

• Estradiol Limits ER Stress After Hemorrhagic Shock

  2026-09-23

  In a rat hemorrhagic-shock model, estradiol was associated with improved splenic CD4+ T-cell proliferation and cytokine production, alongside reduced endoplasmic reticulum stress. Pharmacological interventions implicated ERα and GPR30, but not ERβ, and suggest that ER-stress control is relevant to immune recovery in this acute model.

• hiPSC Intestinal Organoids for Pharmacokinetics

  2026-09-23

  Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable intestinal organoids from human induced pluripotent stem cells. The resulting organoids can be expanded, cryopreserved, and differentiated into intestinal epithelial cells with enterocyte metabolic and transporter activities relevant to oral drug pharmacokinetics.

• Lanabecestat: Designing Better BACE1 Assays

  2026-09-22

  Lanabecestat (AZD3293) enables a more informative approach to Alzheimer’s disease research: linking BACE1 inhibition and amyloid-beta reduction with functional neuronal measurements. This article explains how to design exposure-response assays that distinguish useful partial amyloidogenic pathway modulation from broader synaptic disruption.

• In Vitro Drug Responses: Separating Growth from Cell Death

  2026-09-22

  Hannah R. Schwartz’s dissertation shows why cancer drug response cannot be represented adequately by a single viability value: growth inhibition and cell killing are related but distinct outcomes. Its paired-measurement framework offers a practical basis for designing assays, interpreting apoptosis data, and improving translational comparisons across cancer models.

• Annexin V-Cy5/DAPI Apoptosis Kit Workflow

  2026-09-21

  Build a rapid two-parameter cell death workflow that distinguishes phosphatidylserine exposure from loss of membrane integrity. The Annexin V-Cy5/DAPI Apoptosis Kit is especially useful for connecting TKI response, mitochondrial stress, and apoptosis phenotypes in Ph+ ALL models.

• Nullscript: Practical HDAC Assay Workflows

  2026-09-21

  Nullscript is a structurally distinctive histone deacetylase inhibitor for separating HDAC-dependent biology from transcriptional-facilitation effects. This workflow guide covers formulation, cell assays, cardiac I/R interpretation, pathway-focused validation, and troubleshooting without overstating preclinical evidence.

• Targeted mRNA Nanoparticles Repair the Poststroke BBB

  2026-09-20

  The ACS Nano study developed mannose-targeted lipid nanoparticles carrying IL-10 mRNA to redirect microglial responses in ischemic brain lesions. In mouse stroke models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and supported functional recovery, while illustrating both the promise and translational limits of targeted mRNA delivery.

• HyperScribe SP6 High Yield RNA Synthesis Kit Guide

  2026-09-19

  Build high-yield RNA transcripts for probes, translation, RNA interference experiments, and mechanistic studies of antiviral signaling. This workflow combines practical SP6 transcription guidance with assay choices inspired by the GADD34–IRF3 findings reported in SARS-CoV-2 research.

• JC-1 Mitochondrial Membrane Potential Assay Kit Guide

  2026-09-18

  The JC-1 Mitochondrial Membrane Potential Assay Kit converts mitochondrial depolarization into a practical red-to-green fluorescence readout for apoptosis assay design, mitochondrial function analysis, and natural-product screening. Applied to the aureonitol herbicide study, it offers a complementary way to test whether ROS-associated growth inhibition is accompanied by mitochondrial dysfunction.

• Protecting Lysosomal Repair Signals in Translation

  2026-09-18

  Lysosomal repair is a dynamic, protease-sensitive process that can be distorted during sample preparation. This thought-leadership article connects TECPR1-mediated membrane tubulation under energy stress with practical strategies for preserving protein complexes, phosphorylation-sensitive signals, and native structure. It explains how an EDTA-free formulation supports mechanistic studies without introducing unnecessary metal chelation, while offering protocol guidance, competitive positioning, translational cautions, and a forward-looking framework for connecting organelle biology with reproducible assay design.

7944 records 6/530 page Previous Next First page 上5页 678910 下5页 Last page